SNT 10.6% 5.2¢ syntara limited

Bronchitol break into Switzerland.

  1. 7,165 Posts.
    lightbulb Created with Sketch. 546
    https://finance.yahoo.com/news/effrx-pharmaceuticals-signs-exclusive-license-120000152.html.
    ============

    EffRx Pharmaceuticals SA, a commercial-stage company that commercializes niche and orphan medicines in Switzerland and Europe, today announced it has entered into an exclusive license agreement with Pharmaxis Ltd, a listed pharmaceutical research company in Australia, for the registration and commercialization of Bronchitol® (mannitol) for cystic fibrosis in Switzerland.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.